Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients

Objective Circulating endothelial progenitor cells (EPCs) differentiate into mature endothelial cells and regenerate the injured endothelium. The role of homeobox A9 (HOXA9) is critical for endothelial commitment during progenitor cell maturation, postnatal neovascularization and vascular repair. The objective of our study was to measure the expression of HOXA9 in CD34+ cells from hypertensive patients and to investigate its correlation with the number of circulating EPCs. Methods Thirty patients with newly diagnosed, never-treated essential hypertension and 30 age- and sex-matched normotensive controls were recruited for the study. Total RNA was extracted from peripheral CD34+ cells and quantitative real-time polymerase chain reaction for measurement of HOXA9 expression was performed. The number of CD34+/human kinase insert domain protein receptor + (KDR+) EPCs was measured and the Framingham risk estimated. Results Hypertensive patients had reduced HOXA9 expression compared to normotensive subjects (−26%, P < 0.001), and lower levels of peripheral CD34+/KDR+ EPCs (421 ± 93 versus 582 ± 101, P < 0.001). HOXA9 expression was inversely associated with systolic blood pressure (r = −0.54, P < 0.001) and the Framingham risk (r = −0.50, P < 0.001). A direct association was observed between the number of EPCs and HOXA9 expression (r = 0.50, P < 0.001), which was independent of blood pressure levels and Framingham risk. In a subgroup of 15 hypertensive patients, a 4-week treatment with ramipril was associated with a significant 15% increase in HOXA9 expression and 25% increase in EPC levels. Conclusions In hypertensive patients, downregulation of HOXA9 expression in peripheral CD34+ cells may have a role in the loss of circulating EPCs, thus potentially impairing postnatal neovascularization and vascular repair.

[1]  X. Rabasseda.  New joint European Society of Hypertension/European Society of Cardiology guidelines for the management of arterial hypertension. , 2007, Timely topics in medicine. Cardiovascular diseases.

[2]  R. Paltriccia,et al.  Increased Ratio of CD31+/CD42− Microparticles to Endothelial Progenitors as a Novel Marker of Atherosclerosis in Hypercholesterolemia , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[3]  G. Nickenig,et al.  Improvement of Endothelial Function by Systemic Transfusion of Vascular Progenitor Cells , 2006, Circulation research.

[4]  A. Avogaro,et al.  Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. , 2006, European heart journal.

[5]  G. Nickenig,et al.  Clinical and therapeutical implications of EPC biology in atherosclerosis , 2006, Journal of cellular and molecular medicine.

[6]  T. Rabelink,et al.  Endothelial progenitor cells: biology and therapeutic potential in hypertension , 2006, Current opinion in nephrology and hypertension.

[7]  Qingbo Xu.  The impact of progenitor cells in atherosclerosis , 2006, Nature Clinical Practice Cardiovascular Medicine.

[8]  T. Imanishi,et al.  Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension , 2005, Journal of hypertension.

[9]  G. Nickenig,et al.  Circulating endothelial progenitor cells and cardiovascular outcomes. , 2005, The New England journal of medicine.

[10]  S. Fichtlscherer,et al.  Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events: Proof of Concept for the Clinical Importance of Endogenous Vascular Repair , 2005, Circulation.

[11]  E. Chavakis,et al.  Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells , 2005, The Journal of experimental medicine.

[12]  R. Humphries,et al.  Activation of Stem‐Cell Specific Genes by HOXA9 and HOXA10 Homeodomain Proteins in CD34+ Human Cord Blood Cells , 2005, Stem cells.

[13]  T. Imanishi,et al.  Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress , 2005, Journal of hypertension.

[14]  N. V. van Riel,et al.  Mathematical modeling of vascular endothelial layer maintenance: the role of endothelial cell division, progenitor cell homing, and telomere shortening. , 2004, American journal of physiology. Heart and circulatory physiology.

[15]  Xing-xiang Wang,et al.  Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. , 2004, Clinical science.

[16]  Tao Min,et al.  Improvement in Endothelial Progenitor Cells from Peripheral Blood by Ramipril Therapy in Patients with Stable Coronary Artery Disease , 2004, Cardiovascular Drugs and Therapy.

[17]  A. Zeiher,et al.  Homeobox A9 Transcriptionally Regulates the EphB4 Receptor to Modulate Endothelial Cell Migration and Tube Formation , 2004, Circulation research.

[18]  T. Imanishi,et al.  Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells. , 2004, Hypertension research : official journal of the Japanese Society of Hypertension.

[19]  S. Priori,et al.  2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial Hypertension , 2003, Heart Drug.

[20]  A. Quyyumi,et al.  Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. , 2003, The New England journal of medicine.

[21]  Richard A. Preston,et al.  Effects of Severe Hypertension on Endothelial and Platelet Microparticles , 2003, Hypertension.

[22]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[23]  E. Schiffrin,et al.  A Critical Review of the Role of Endothelial Factors in the Pathogenesis of Hypertension , 2001, Journal of cardiovascular pharmacology.

[24]  F. Perticone,et al.  Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients , 2001, Circulation.

[25]  S. Fichtlscherer,et al.  Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease , 2001, Circulation research.

[26]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[27]  F. Ruschitzka,et al.  Working under pressure: the vascular endothelium in arterial hypertension , 2000, Journal of Human Hypertension.

[28]  K. Kohara,et al.  Low wall shear stress contributes to atherosclerosis of the carotid artery in hypertensive patients. , 1999, Hypertension research : official journal of the Japanese Society of Hypertension.

[29]  P. Dicorleto,et al.  Endothelial Cells Express a Novel, Tumor Necrosis Factor-α-regulated Variant of HOXA9 * , 1999, The Journal of Biological Chemistry.

[30]  S. Bandyopadhyay,et al.  Endothelial cells express a novel, tumor necrosis factor-alpha-regulated variant of HOXA9. , 1999, The Journal of biological chemistry.

[31]  M. Magli,et al.  Effects of HOX homeobox genes in blood cell differentiation , 1997, Journal of cellular physiology.

[32]  G. Sauvageau,et al.  Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Simon,et al.  Abnormal wall shear conditions in the brachial artery of hypertensive patients. , 1990, Journal of Hypertension.